Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 25 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Disease burden of Hepatitis B-related hepatocellular carcinoma

This month's issue of the Journal of Viral Hepatitis examines Hepatitis B-related hepatocellular carcinoma.

News image

fiogf49gjkf04

Worldwide, 350 million people are chronically infected with hepatitis B virus  who are at greater risk of hepatocellular carcinoma compared with uninfected people.

Dr Nguyen and colleagues from Australia explored the epidemiology and disease burden of Hepatits B-related hepatocellular carcinoma.

The relative risks of hepatocellular carcinoma among people infected with hepatitis B virus ranges from 5 to 49 in case–control studies and from 7 to 98 in cohort studies.

More than 50% of hepatocellular carcinoma cases worldwide, and 70–80% of hepatocellular carcinoma cases in highly hepatitis B virus endemic regions are attributable to hepatitis B virus.

The team found that the incidence of hepatocellular carcinoma (per 100 000 person/year) among people with chronic hepatitis B virus infection ranges from 400 to 800 in male and from 120 to 180 in female.
Survival rates of hepatitis B virus-related hepatocellular carcinoma  ranged from 36% to 67% after 1 year.

Journal of Viral Hepatitis

Factors associated with increased risk of hepatocellular carcinoma  include demographic characteristics, and lifestyles.

In addition, viral factors (genotype C, D F, high level of hepatitis B virus  DNA, core/precore mutation), clinical factors (cirrhosis, elevated alpha-fetoprotein and alanine aminotransferase) increased the risk.

The researchers found that hepatitis B virus-related hepatocellular carcinoma has extremely poor prognosis with median survival less than 16 months.

Survival rates of hepatitis B virus-related hepatocellular carcinoma  ranged from 36% to 67% after 1 year, and from 15% to 26% after 5 year of diagnosis.

Older age, liver function impairment, vascular invasion, tumour aggressiveness and elevated AFP are associated with hepatocellular carcinoma  survival.

Global burden of hepatitis B virus -related liver disease is still a major challenge for public health in the 21st century.

The team found that while decreases in incidence of hepatitis B virus  infection have been observed in birth cohorts following the introduction of universal infant hepatitis B virus vaccination program.

Hepatitis B virus-related hepatocellular carcinoma incidence is projected to increase for at least 2 decades.

This projected increase is because of the high prevalence of chronic hepatitis B virus infection, and prolonged latency to hepatocellular carcinoma  development.

Dr Nguyen's team concluded, “To reduce hepatitis B virus-related hepatocellular carcinoma continued expansion of universal infant hepatitis B virus vaccination is required along with antiviral therapy targeted to those individuals at highest risk of hepatocellular carcinoma.”

“Broad public health strategies should include routine testing to identify chronic hepatitis B virus infection, improved health infrastructures including human resource to provide diagnosis and treatment assessment.”

J Vir Hep 2009: 16(7): 453-63
15 June 2009

Go to top of page Email this page Email this page to a colleague

 25 May 2018 
Colorectal cancer–specific mortality
 25 May 2018 
Technology to increase colorectal cancer screening
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
Hep B in the Grey Zone
 15 May 2018 
New therapies for CDI
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Post‐operative complications in elderly IBD
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us